A 25-year-old woman presented with ophthalmic and neurological manifestations. Her ocular manifestations included bilateral uveitis, multifocal retinal phlebitis, vitreitis and multiple retinal haemorrhages.
CASE REPORT
A 25-year-old woman presented in 1994 to the ophthalmology department with sustained episodes of flashes affecting the vision in both eyes. She was morbidly obese weighing 140 kg and a smoker. On examination, her optic discs and fundi were normal, but she was noted to have a transient drop in her visual acuity that normalized over a few days. For the on-going troublesome migrainous phenomenon, she was referred to neurology where she reported episodes of blurred vision, paraesthesia in the left lower jaw, left arm and leg. She was experiencing monthly right-sided headaches, associated with photophobia, which resolved within 24 hours. Examination was normal with no evidence of focal neurological deficit. Multiple sclerosis was considered as a diagnosis but later deemed unlikely. She was thought to have complicated migraine, and she was discharged. In 1998, she was re-referred to the neurology department with intermittent tingling on both sides of her body. This was accompanied by a sensation of imbalance. She had some short lasting visual obscuration. Neurological examination was normal. A magnetic resonance imaging (MRI) of the brain was organized but could not be performed due to morbid obesity. In 2002, she presented to the emergency eye department with bilateral granulomatous uveitis. Retinal fundoscopy revealed multifocal retinal periphlebitis. The optic discs appeared healthy, and there was no retinal cystoid macular oedema. Blood tests showed a normal ANA, antiphospholipid screen, full blood count, an ESR of 28 mm/hour and the presence of an atypical ANCA. The ANCA prompted a referral to the rheumatology department. An MRI of the brain showed lesions that involved the deep white matter (Fig. 1) . Over the next few years, she was monitored in a combined rheumatologyneurology clinic. Neurological examination remained normal. A Lumbar Puncture (LP) was not performed due to the body habitus. Visual evoked potentials were normal. Between 2002 and 2004, she had episodes of vitritis, hypopyon and macular oedema needing large doses of oral prednisolone. There was debate about this being a demyelinating process versus a vasculitis process, and it was decided that she should be treated with six cycles of intravenous cyclophosphamide followed by mycophenolate mofetil. However, in spite of the treatment, in 2005 she had a further episode of retinal haemorrhage and a posterior circulation transient ischaemic attack. A repeat MRI of the brain revealed progression of the number and distribution of white matter lesions with multifocal deep grey matter and brain stem involvement (Fig. 2) . Considering this to represent small vessel disease, possibly due to vasculitis, she was commenced on aspirin, b-blocker and statin. From 2004-2010, she continued to have attacks of uveitis and retinal bleeds, which were treated with a high dose of prednisolone. At this stage, an MRI was repeated to monitor the central nervous system changes. The MRI demonstrated progressive disease, which is, though nonspecific, more suggestive of multifocal small vessel disease. The unusual distribution of the lesions and clinical progression sparked the search for alternative diagnoses. A review of the entire history and a multi-disciplinary discussion between the ophthalmology, rheumatology and neurology departments considered potential differential diagnoses-CADASIL, Susac syndrome and neurological Behcet's disease. A negative genetic screen ruled out CADASIL. The lack of auditory involvement made Susac syndrome unlikely. Further history of intermittent oral and vaginal ulcers in her teens was obtained. This history had been lost because the patient had not considered this to be important and this had not been a problem for a number of years because of on-going oral prednisolone (doses of > 10 mg daily). A clinical diagnosis of Behcet's disease was made. She fulfilled the classification criteria as set by the International Study Group for Behcet's disease [1] . She was commenced on infliximab and azathioprine in 2013, which was later switched to methotrexate due to azathioprine intolerance. Since then she had no further episodes of uveitis, and her subsequent MRIs of the brain revealed stable appearances. At last follow-up she remained stable and is back in full-time employment.
DISCUSSION
Behçet's disease is a systemic vasculitis of unknown aetiology involving vessels of all sizes, characterized by orogenital ulceration, ocular and neurological involvement. Its clinical manifestations may not occur simultaneously; therefore, a high index of suspicion is required, and a detailed past history is crucial to its diagnosis [2] . A diagnosis of cerebral and retinal vasculitis had been made and sustained in medical notes in our patient. The finding of temporal lobe atrophy in such a young woman caused us to look for more sustainable diagnoses-leading to a definite diagnosis of Behcet's disease. She presented initially with vague migrainous headaches with visual aura, transient sensory symptoms and episodes of blurred vision. Initial ophthalmological and neurological examinations were normal. Years later she re-presented with bilateral uveitis, which persisted for years, and also developed a posterior circulation stroke. She was treated for retinal vasculitis with systemic immunosuppression (cyclophosphamide and mycophenolate mofetil) with recurrence of uveitis episodes [3] . Interestingly her neurological examination and cognition remained normal throughout the years. Her MRI of the brain demonstrated progressive white matter, deep grey matter and brain stem disease consistent with multifocal small vessel disease. Her non-response to treatment triggered a re-consideration of her case after many years of having been classified as cerebral and retinal vasculitis. Further history elicited a past episode of oral and genital ulcers in her teen age years, which she did not complain of because they had always been steroid responsive, and she did not consider them to be relevant. On the basis of the MRI lesions, re-current episodes of uveitis and orogenital ulcers, she was diagnosed with Behçet's disease and commenced on Infliximab and azathioprine as per the EULAR recommendations [4] [5] [6] . Correct identification of the nature of the vasculitis illness and treating it with the correct medication resulted in excellent long-term outcomes resulting in no further retinal bleeds and a return to full-time employment.
KEY LEARNING POINTS
It is important to re-evaluate patients with long-term diagnoses when the clinical profile does not fit. It is easy to be biased with previously made diagnoses. But logical re-interpretation of existing data can provide plausible alternatives.
Classification of vasculitis is not just for academic purposes. Correct classification leads to correct medical treatment, which in-turn leads to better patient-related outcomes.
Behcet's disease is a clinical diagnosis that can present with sequential manifestations. Vasculitis should be thought of as a diagnosis in all patients with multi-organ involvement.
